The beneficiary
SCLAVO VACCINES ASSOCIATION
FONDAZIONE BIOTECNOPOLO di Siena
The project
The European Vaccine Hub (EVH) for Pandemic Preparedness project aims to improve Europe's vaccine preparedness and response capacity in the event of a pandemic by creating a collaborative network of nationally-funded vaccine R&D initiatives. It brings together leading European organisations, including Biotecnopolo, Institut Pasteur, Vaccinopolis (Antwerp), DZIF and ZEPAI, which specialise in vaccine development and pandemic preparedness.
The platform will initially focus on H5N1 and universal influenza to test its end-to-end pipeline, with additional activities for SARS-CoV-2, monkeypox and flaviviruses. By aligning EU resources and expertise, the EVH will create a comprehensive pandemic vaccine preparedness plan to protect Europe's citizens and economy.
This project will enable European players in charge of vaccine development to become more structured, with the aim of anticipating future pandemics.
The financing programme
Programme EU4Health - HERA Actions
Public funding
Key figures:
- Budget total project: € € € € € € € € € € € € € € € € € € € € € € € € 169 992 331.
- Amount of grant : € 101 995 399.
- Duration Project duration: 4 years (2025-2029)
Partnership:
- 8 main partners, 17 associate partners.
- Support from numerous industrial partners
- Support for numerous European and international initiatives.
Our contribution
- Scinnov was involved in developing the project and drafting the funding application within a very short timeframe (2.5 months), mobilising a team that complemented the expertise and resources provided by the main partners.
- Brainstorming: taking part in brainstorming sessions with project stakeholders to define the project's scope, objectives and priorities.
- Preparing your funding application Analysis of contextual elements, assistance in defining strategic priorities, managing preparation deadlines and gathering the necessary information. Drafting horizontal sections, checking compliance with funding requirements and ensuring a convincing, well-structured proposal.
- Integration of industrial partners The consortium: helping to identify, engage and integrate industrial partners, encouraging collaboration and aligning partner roles to strengthen the consortium's value proposition.
- Budget Help in drawing up a detailed, realistic budget that complies with EU guidelines, including eligible costs, staff, travel, subcontracting and indirect costs.
The result of the project
The project was submitted in September 2024 and selected by the European Commission in December 2024. The project has also received the seal of European sovereignty (STEP SEAL - Strategic Technologies for Europe Platform)
It will create the European Vaccine Hub (EVH), a European centre for the development of vaccines relevant to public health, combining excellence in the development of vaccines and human monoclonal antibodies (H-mAbs) with clinical trials and large-scale manufacturing activities.
English (UK) 
Français